Log in
Enquire now
‌

US Patent 7071331 Synthesis of quetiapine and pharmaceutically acceptable salts thereof

Patent 7071331 was granted and assigned to Teva Pharmaceutical Industries on July, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
70713310
Patent Inventor Names
Ben-Zion Dolitzky0
Dov Diller0
Date of Patent
July 4, 2006
0
Patent Application Number
107852440
Date Filed
February 23, 2004
0
Patent Citations Received
‌
US Patent 12023340 Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
0
Patent Primary Examiner
‌
Brenda Coleman
0
Patent abstract

Provided is a novel synthesis of quetiapine employing phase transfer catalyst.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7071331 Synthesis of quetiapine and pharmaceutically acceptable salts thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.